Nissinen A, Tuomilehto J
Pharmatherapeutica. 1980;2(7):462-8.
A double-blind, within-patient study was carried out in 23 newly diagnosed patients with mild to moderate hypertension (diastolic blood pressure of at least 100 mmHg) to compare the antihypertensive effects of atenolol (100 mg) and chlorthalidone (25 mg) given in free and fixed combination. After a 4-week placebo run-in period, patients received each of the two active treatments and also placebo for periods of 4 weeks, the treatment sequence being randomized. A single daily drug dose was taken 24 to 28 hours before each blood pressure measurement at 2-weekly intervals. The results showed that both active drug combinations lowered lying, standing and post-exercise blood pressure significantly and there was no statistical difference between the two forms of treatment. Two-thirds of the patients were adequately controlled with the single daily dose regimen and few side-effects were reported.
对23例新诊断的轻度至中度高血压患者(舒张压至少为100mmHg)进行了一项双盲、患者自身对照研究,以比较阿替洛尔(100mg)和氯噻酮(25mg)自由组合及固定组合的降压效果。经过4周的安慰剂导入期后,患者接受两种活性治疗药物及安慰剂,每种治疗为期4周,治疗顺序随机安排。在每隔2周测量血压前24至28小时服用单一剂量的每日药物。结果显示,两种活性药物组合均能显著降低卧位、立位及运动后血压,两种治疗方式之间无统计学差异。三分之二的患者采用每日单剂量方案得到了充分控制,且报告的副作用较少。